• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

COVID forgotten communities
Newsletters
The communities we forget during COVID-19
By Sy MukherjeeApril 30, 2020
Gilead remdesivir coronavirus FDA
Health
Gilead’s remdesivir won’t be a COVID-19 miracle cure, but it’s still an important first step
By Sy MukherjeeApril 30, 2020
The coronavirus pandemic is impacting critical research into neuromuscular diseases
Health
The coronavirus pandemic is impacting critical research into neuromuscular diseases
By Sy MukherjeeApril 28, 2020
Coronavirus treatment approach
Newsletters
The 3-pronged approach to defeating the coronavirus
By Sy MukherjeeApril 23, 2020
Elective surgeries—mostly paused due to the pandemic—are critical to hospital finances
Health
Elective surgeries—mostly paused due to the pandemic—are critical to hospital finances
By Sy MukherjeeApril 23, 2020
Big Pharma has the chance to come to the world’s rescue
Magazine
Big Pharma has the chance to come to the world’s rescue
By Sy MukherjeeApril 20, 2020
Coronavirus tests and their discontents
Newsletters
Coronavirus tests and their discontents
By Sy MukherjeeApril 16, 2020
Coronavirus Drive Thru Testing Penn State Health Saint Joseph
Health
There are 32 authorized coronavirus tests so far—here’s how they differ
By Sy MukherjeeApril 10, 2020
The key problem to solve in the quest for coronavirus treatments
Newsletters
The key problem to solve in the quest for coronavirus treatments
By Sy MukherjeeApril 9, 2020
Joe Biden’s health care plan for the coronavirus and beyond
Health
Joe Biden’s health care plan for the coronavirus and beyond
By Sy MukherjeeApril 3, 2020
Coronavirus earth
Newsletters
Coronavirus is (literally) shaking up how the world moves
By Sy MukherjeeApril 2, 2020
J&J coronavirus
Newsletters
J&J’s coronavirus vaccine could hit the market by 2021
By Sy MukherjeeMarch 30, 2020
Johnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021
Health
Johnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021
By Sy MukherjeeMarch 30, 2020
Coronavirus cases U.S.
Newsletters
The U.S. now has the most coronavirus cases in the world
By Sy MukherjeeMarch 27, 2020
Henry Schein says its coronavirus test takes just 15 minutes, and there’s no swab necessary
Newsletters
Henry Schein says its coronavirus test takes just 15 minutes, and there’s no swab necessary
By Sy MukherjeeMarch 26, 2020
1...
  • 16
  • 17
  • 18
  • 19
  • 20
...100
Most Popular
Economy
Florida voters nearly tripled the homeowner tax break — blowing an $11.8 billion hole in county budgetsplaceholder alt text
By Abigail Hall, Aaron D. Wood and The ConversationNovember 6, 2026
Politics
'Like being hit between the eyes with a sledgehammer': Meet the one town in America that defied election trends and voted in favor of data centersplaceholder alt text
By Sasha RogelbergNovember 7, 2026
Economy
Bill Gates believes a billionaire's tax is the only option in the age of AI—and 'whatever's left over' can be used as a philanthropic safety netplaceholder alt text
By Eleanor PringleNovember 6, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.